首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury.
【24h】

Soluble vascular adhesion protein-1: decreased activity in the plasma of trauma victims and predictive marker for severity of traumatic brain injury.

机译:可溶性血管黏附蛋白-1:创伤患者血浆中的活性降低,是创伤性脑损伤严重程度的预测指标。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: This study done was to investigate the clinical significance of soluble vascular adhesion protein-1 (sVAP-1) activity in trauma patients with different patterns. METHODS: 96 patients with consecutive trauma >/=15 years who were admitted to emergency department of the Second Affiliated Hospital, Shantou University Medical College, China, between January 2007 and December 2009 were enrolled in this study. Plasma was collected at admission. Injury-severity score (ISS) and Glasgow Coma Scale (GCS) were used to determine the patient conditions. sVAP-1 activity was determined by using the high performance liquid chromatographic (HPLC) system. RESULTS: Mean sVAP-1 activity in trauma patients was significantly lower than that of controls (P<0.0001), and the level was negatively correlated with circulating leucocytes and neutrophils (P<0.0001). There was a significant correlation between lower sVAP-1 activity and injury patterns. However, plasma sVAP-1 activity increased significantly in accordance with the severity of traumatic brain injury (TBI), and the patients with sVAP-1 value above 8.61 nmol/ml/h have much higher mortality rate (25.0%) than patients with sVAP-1 value lower than 8.61 nmol/ml/h (0.0%) (P=0.011). CONCLUSIONS: Trauma patients had a decreased sVAP-1 activity. However, isolated TBI patients with higher activity of sVAP-1 at admission were more likely to have a poor outcome.
机译:背景:本研究旨在探讨不同模式创伤患者的可溶性血管黏附蛋白-1(sVAP-1)活性的临床意义。方法:本研究纳入了2007年1月至2009年12月在中国汕头大学医学院附属第二医院急诊科就诊的连续创伤≥15年的96例患者。入院时收集血浆。使用损伤严重程度评分(ISS)和格拉斯哥昏迷量表(GCS)来确定患者的状况。 sVAP-1活性是通过使用高效液相色谱(HPLC)系统确定的。结果:创伤患者的平均sVAP-1活性显着低于对照组(P <0.0001),且水平与循环白细胞和中性粒细胞呈负相关(P <0.0001)。较低的sVAP-1活性与损伤模式之间存在显着相关性。然而,血浆sVAP-1活性随脑外伤的严重程度而显着增加,并且sVAP-1值高于8.61 nmol / ml / h的患者的死亡率(25.0%)比sVAP的患者高得多-1值低于8.61 nmol / ml / h(0.0%)(P = 0.011)。结论:创伤患者的sVAP-1活性降低。然而,入院时具有较高sVAP-1活性的孤立TBI患者更有可能出现不良预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号